CBD Life Sciences (OTCMKTS:CBDL) Stock Continues to Trade in a Narrow Range
Shares of CBD Life Sciences (OTCMKTS:CBDL) have been consolidating over the past sessions.
Market Stats
On Thursday, CBDL stock ended flat at $0.0002 with more than 98.86 million shares, compared to its average volume of 124.12 million shares. The stock moved within a range of $0.0001 – 0.0003 after opening trading at $0.0002.
CBD Life Sciences Set to Demonstrate their Best Products at ERRL Cup Cannabis Event
CBD Life Sciences, (OTCMKTS:CBDL) via its wholly owned subsidiary, LBC Bioscience Inc. has announced on March 10, 2022 that the company is all set to go for the ERRL Cup Cannabis Event this weekend from March 12th-13th located in Mesa, Arizona.
CBD Life Sciences Inc. is thrilled to have the opportunity to showcase some of its best products at Arizona’s biggest Cannabis awards and festival event. The products will be displayed in front of dispensaries, distributors, and other big retail giants around the world.
President and CEO Lisa Nelson states that participating in these huge events throughout the year has shown results that are simply outstanding! The company has experienced increased growth as more places have expressed a keen interest in carrying their products and putting those on their shelves.
The objective of attending these events is to raise brand awareness among industry professionals and key decision makers that matter. CBD has a plethora of benefits, such as helping with behavioral/neurological complications such as ADD/ADHD, anxiety, autism, bipolar, OCD, PTSD, epilepsy, Parkinson’s, osteoporosis, and ALS, to name a few. Studies have also shown promising results when it comes to pain management that could stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia.
Traders Corner
CBDL stock is trading below the 20-Day and 50-Day Moving averages of $0.0002 and $0.0002 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.0003.
